Haahtela T, Tuomisto L E, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen M M, Kontula E, Laitinen L A
Skin and Allergy Hospital, Helsinki University Central Hospital, P O Box 160, FIN-00029 HUS, Finland.
Thorax. 2006 Aug;61(8):663-70. doi: 10.1136/thx.2005.055699.
A National Asthma Programme was undertaken in Finland from 1994 to 2004 to improve asthma care and prevent an increase in costs. The main goal was to lessen the burden of asthma to individuals and society.
The action programme focused on implementation of new knowledge, especially for primary care. The main premise underpinning the campaign was that asthma is an inflammatory disease and requires anti-inflammatory treatment from the outset. The key for implementation was an effective network of asthma-responsible professionals and development of a post hoc evaluation strategy. In 1997 Finnish pharmacies were included in the Pharmacy Programme and in 2002 a Childhood Asthma mini-Programme was launched.
The incidence of asthma is still increasing, but the burden of asthma has decreased considerably. The number of hospital days has fallen by 54% from 110 000 in 1993 to 51 000 in 2003, 69% in relation to the number of asthmatics (n = 135 363 and 207 757, respectively), with the trend still downwards. In 1993, 7212 patients of working age (9% of 80 133 asthmatics) received a disability pension from the Social Insurance Institution compared with 1741 in 2003 (1.5% of 116 067 asthmatics). The absolute decrease was 76%, and 83% in relation to the number of asthmatics. The increase in the cost of asthma (compensation for disability, drugs, hospital care, and outpatient doctor visits) ended: in 1993 the costs were 218 million euro which had fallen to 213.5 million euro in 2003. Costs per patient per year have decreased 36% (from 1611 euro to 1031 euro).
It is possible to reduce the morbidity of asthma and its impact on individuals as well as on society. Improvements would have taken place without the programme, but not of this magnitude.
1994年至2004年期间,芬兰实施了一项全国哮喘计划,旨在改善哮喘护理并防止成本增加。主要目标是减轻哮喘对个人和社会的负担。
该行动计划侧重于新知识的实施,尤其是针对初级护理。该运动的主要前提是哮喘是一种炎症性疾病,从一开始就需要抗炎治疗。实施的关键是建立一个有效的哮喘责任专业人员网络,并制定事后评估策略。1997年,芬兰药房被纳入药房计划,2002年启动了儿童哮喘小型计划。
哮喘发病率仍在上升,但哮喘负担已大幅下降。住院天数从1993年的11万天下降了54%,至2003年的5.1万天,相对于哮喘患者数量(分别为135363人和207757人)下降了69%,且仍呈下降趋势。1993年,7212名工作年龄患者(占80133名哮喘患者的9%)从社会保险机构领取了残疾抚恤金,而2003年为1741名(占116067名哮喘患者的1.5%)。绝对减少了76%,相对于哮喘患者数量减少了83%。哮喘成本(残疾补偿、药物、住院护理和门诊医生诊疗)的增长结束了:1993年成本为2.18亿欧元,2003年降至2.135亿欧元。每位患者每年的成本下降了36%(从1611欧元降至1031欧元)。
降低哮喘发病率及其对个人和社会的影响是可能的。即使没有该计划,情况也会有所改善,但不会达到如此程度。